US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class III · Low risk Terminated

Cequa

Reason Subpotent and Presence of Particulates .

Sun Pharmaceutical Industries INC NDC 47335-506-96 D-0391-2021
Class II · Moderate risk Completed

BusPIRone Hydrochloride Tablets

Reason Presence of Foreign Tablets/Capsules

Oxford Pharmaceuticals, LLC NDC 69584-093-10 D-0602-2021
Class II · Moderate risk Terminated

Micardis Tablets

Reason Subpotent Drug

Boehringer Ingelheim Pharmaceuticals, Inc. NDC 0597-0041-37 D-0600-2021
Class III · Low risk Terminated

Atorvastatin Calcium Tablets

Reason Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities

Dr. Reddy's Laboratories, Inc. NDC 55111-121-05 D-0599-2021
Class II · Moderate risk Terminated

Metformin HCl Extended-Release Tablets

Reason Presence of foreign substance: identified as activated carbon.

Sun Pharmaceutical Industries INC NDC 62756-142-02 D-0372-2021
Class I · High risk Terminated

1% Lidocaine HCl Injection

Reason Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP

Pfizer, INC NDC 0409-4279-16 D-0627-2021
Class I · High risk Terminated

0.5% Bupivacaine Hydrochloride Injection

Reason Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP

Pfizer, INC NDC 0409-1162-19 D-0626-2021
Class III · Low risk Terminated

Thiamine HCl Injection

Reason Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.

Mylan Institutional LLC D-0601-2021
Class II · Moderate risk Terminated

Sterile Water for Inj.

Reason Presence of Particulate Matter: particulate matter identified as an insect in one vial.

Pfizer Inc. D-0384-2021
Class I · High risk Terminated

NP Thyroid 120 Thyroid Tablets

Reason Subpotent Drug

Acella Pharmaceuticals, LLC NDC 42192-328-01 D-0399-2021
Class I · High risk Terminated

NP Thyroid 90 Thyroid Tablets

Reason Subpotent Drug

Acella Pharmaceuticals, LLC NDC 42192-331-01 D-0398-2021
Class I · High risk Terminated

NP Thyroid 60 Thyroid Tablets

Reason Subpotent Drug

Acella Pharmaceuticals, LLC NDC 42192-330-01 D-0397-2021
Class I · High risk Terminated

NP Thyroid 30 Thyroid Tablets

Reason Subpotent Drug

Acella Pharmaceuticals, LLC NDC 42192-329-01 D-0396-2021
Class I · High risk Terminated

NP Thyroid 15 Thyroid Tablets

Reason Subpotent Drug

Acella Pharmaceuticals, LLC NDC 42192-327-01 D-0395-2021
Class III · Low risk Terminated

Olmesartan Medoxomil Tablets

Reason Presence of Foreign Tablet/Capsule

Ascend Laboratories LLC NDC 67877-446-30 D-0392-2021
Class II · Moderate risk Terminated

Sodium Chloride 0.9%

Reason Temperature Abuse: Product exposed to temperature outside specified limits.

Fresenius Medical Care Holdings, Inc. NDC 46163-0300-10 D-0603-2021
Class II · Moderate risk Ongoing

Preferred Pharmaceuticals Inc.

Reason CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.

Preferred Pharmaceuticals, Inc. D-0385-2021